Logo image
Dexmedetomidine's effect on neonatal sedation, pain, respiratory status and cardiovascular system
Journal article   Peer reviewed

Dexmedetomidine's effect on neonatal sedation, pain, respiratory status and cardiovascular system

Marjorie M Makoni, Ivonne Sierra-Strum, Adrianne R Bischoff, Jamie L Miller, Lise DeShea, William Howard Beasley and Edgardo Szyld
Journal of perinatology, Vol.45(12), pp.1686-1692
12/2025
DOI: 10.1038/s41372-025-02339-5
PMID: 40908310

View Online

Abstract

To describe the effects of dexmedetomidine on sedation, pain, respiratory status, and hemodynamics in neonates. A retrospective study of 206 infants in a level IV NICU (2016-2021) receiving continuous dexmedetomidine infusion. Pain/sedation scores, BP, vasopressor and inotrope score (VIS), and concomitant sedatives/analgesics (CSA) were recorded before and every 3-4 h for 24 h. Median PMA:32 weeks. Hypotension occurred in 26%, primarily in infants <32weeks PMA, correlating with higher VIS and CSA. CSA use significantly predicted vasopressors/inotrope use. Dexmedetomidine, with CSA, increases cardiovascular instability in preterm infants who have unique myocardial structure and function and therefore higher vulnerability. None (not applicable).

Details

Logo image